The Lancet magazine has published an article on the high efficiency and safety of Light satellite

The Lancet Authoritative Medical Journal has published an article on the high efficiency and safety of the Satellite Light one -component vaccine, which was prepared in the Hamalea Center. This was reported in the Russian Foundation for direct investments (RDIPI).

Materials for the article were collected during the study conducted by the employees of the Center. According to its results, most of the side effects among the test participants were soft or medium. “Serious undesirable phenomena are not registered,” the message also said.

The study also showed the high effectiveness of the drug both with independent use and as an additional vaccine. Including, against the Delta Coronavirus Variant.

Here is a link to the full version of the article in The Lancet magazine.

Now the "satellite of Light" is registered in more than 15 countries, soon this list will be replenished with another 30 states, the RDII noted.

What else to read:

• Earlier it was reported that the Light satellite vaccine disappeared in the regions of Russia. This was also written by Petersburgers, who could not get used to a one -component vaccine in city points. After that, the Ministry of Health of the Russian Federation, which is engaged in the supply of the drug, said that they resumed supplies, but with new recommendations. Read more here .
• Has the number of vaccinated in St. Petersburg changed after announcements about QR codes and Locksa? Show on the graph.